Ubiquinol vs Ubiquinone: Which CoQ10 to Take?

Either form is a reasonable choice for most people. Ubiquinol raised blood CoQ10 more than ubiquinone in two small trials of 10 to 12 adults^{1, 2}, but an 8-week trial of 150 adults across five groups found no significant difference between the two³. The heart failure trials that cut deaths used ubiquinone⁴.

Both are the same molecule, coenzyme Q10 (CoQ10), in its oxidized (ubiquinone) and reduced (ubiquinol) state, and the body converts one into the other^{2, 5}. How the capsule is formulated can matter as much as which state you buy: in one trial a water-soluble syrup outperformed ubiquinol capsules^{6, 5}.

The difference is two electrons. Ubiquinone is the oxidized form of CoQ10, and it must be reduced to ubiquinol in the body to do its jobs: relaying electrons for energy (ATP) production in the mitochondria and acting as a fat-soluble antioxidant².

Ubiquinone is the form most commonly used in commercial supplements, while ubiquinol is sold as the already-reduced form². Both are fat soluble, and because the molecule is large and water-repelling, absorption from the gut is slow and limited whichever form you take⁷.

Does your body convert ubiquinone to ubiquinol?

Yes. In a crossover trial of 21 adults aged 65 to 74, CoQ10 appeared in the blood mostly as ubiquinol even when people swallowed ubiquinone, and the redox state in blood did not differ between formulations⁵. The reverse also happens: in a lab test of 13 ubiquinol products sold in the US, 54% of the ubiquinol turned into ubiquinone in simulated stomach acid and 76% in simulated intestinal fluid⁸.

That lab study was done in test tubes, so it shows what can happen, not what happens in a person⁸. Together these findings explain why the two forms often end up close in the blood.

Ubiquinol came out ahead in the two small multi-week trials, but a single-dose trial and a placebo-controlled 8-week trial found no significant gap^{1, 2, 5, 3}. The head-to-head studies, in order of size:

• 10 older men, 200 mg a day for 2 weeks (crossover): ubiquinol raised total plasma CoQ10 from 1.3 to 3.4 µmol/L, a significant rise; ubiquinone's rise was not significant. Six men responded better to ubiquinol and 2 to ubiquinone².
• 12 healthy adults, 200 mg a day for 4 weeks each (same capsule ingredients): total CoQ10 rose from 0.9 to 2.5 µg/mL on ubiquinone and from 0.9 to 4.3 µg/mL on ubiquinol, a significantly bigger increase (P < 0.005)¹.
• 21 adults aged 65 to 74, one 100 mg dose: ubiquinol capsules delivered 1.7 times the CoQ10 of ubiquinone capsules over 48 hours, but the difference was not significant (95% CI 0.9 to 3.1; p = 0.129)⁵.
• 150 healthy adults split across five groups, label doses of commercial products for 8 weeks (placebo-controlled): plasma CoQ10 rose by 1.46 mg/L with ubiquinone and 2.29 mg/L with ubiquinol, both more than placebo, with no significant difference between the two forms (p ≥ 0.15)³.

The two trials that favoured ubiquinol were tiny and short^{1, 2}. The 2026 trial compared retail products at their own label doses, so it tells you what happens with real products rather than equal doses³.

Is higher blood CoQ10 the same as a better result?

Not necessarily. In the 2-week trial in older men, neither form changed CoQ10 inside white blood cells, cell ATP, or three blood markers of oxidative stress². In the 8-week trial, neither form improved vitality or health questionnaires versus placebo³.

Often, yes. A 2020 review of CoQ10 absorption found that keeping CoQ10 crystals dispersed in the capsule is critical: without it, bioavailability drops by 75%⁶. Solubilized formulations absorb better in general⁷.

In the single-dose trial in older adults, a water-soluble CoQ10 syrup delivered 2.4 times the CoQ10 of standard ubiquinone capsules (p = 0.002), a bigger and clearer gain than ubiquinol capsules achieved⁵. That is the useful frame for questions about phytosome or liposomal CoQ10 versus ubiquinol: the delivery system can matter as much as the redox state, and each product needs its own data⁶.

Because CoQ10 is fat soluble and absorbed slowly, take it with a meal; the 2018 trial gave it with a main meal^{2, 7}. Blood levels peak around 6 hours after a dose⁷.

Ubiquinone, because the trials that showed fewer cardiovascular deaths used it; no ubiquinol trial has reported that result. A 2023 review of 28 clinical trials found that CoQ10 in the ubiquinone form reduced cardiovascular deaths in people with heart failure, a result not reported for ubiquinol; the ubiquinone trials also used lower doses⁴. The authors recommend ubiquinone over ubiquinol for heart failure⁴.

The largest CoQ10 heart failure trial is Q-SYMBIO: 420 people with moderate to severe heart failure took 100 mg of CoQ10 three times a day or placebo for 2 years, on top of standard treatment⁹. Major cardiovascular events occurred in 15% versus 26% (hazard ratio 0.50), and cardiovascular deaths in 9% versus 16%⁹.

• What the Cochrane review says: across 11 trials with 1,573 people, CoQ10 probably lowers all-cause mortality (risk ratio 0.58, based on that one 420-person trial) and heart failure hospital stays (risk ratio 0.62, 2 trials), with moderate-quality evidence¹⁰.
• What is uncertain: effects on heart pumping function and exercise capacity rest on very low-quality evidence¹⁰, and NCCIH calls the heart failure research inconclusive¹¹.

For the full evidence, see CoQ10 for heart failure and our heart health hub. CoQ10 is not a substitute for prescribed heart failure treatment; Q-SYMBIO added it to standard care⁹.

Related conditions

• Heart Failure

No trial has compared the two forms for fertility, so there is no evidence that ubiquinol is better here. The meta-analyses pool trials of CoQ10 in general^{12, 13}:

• Women with low ovarian reserve having IVF or ICSI: 6 randomized trials with 1,529 women found CoQ10 pretreatment linked to a higher clinical pregnancy rate (odds ratio 1.84) and more eggs retrieved; the authors note small samples and poorly described methods¹².
• Men with unexplained infertility: 9 studies with 781 men found CoQ10 raised sperm concentration by about 10 million/mL and motility by about 5 percentage points, and increased the odds of clinical pregnancy (odds ratio 6.02); courses longer than 3 months improved sperm shape¹³.

That male review set out to compare formulations, but its abstract gives no results by form¹³. The pages on CoQ10 for female fertility and CoQ10 for sperm quality cover the trials in detail, and female infertility and male infertility list the other options.

200 mg a day is a common trial dose and well within the safe range. The head-to-head absorption trials used 200 mg a day of either form^{1, 2}, and the Q-SYMBIO heart failure trial used 300 mg a day split into three doses⁹.

• Ubiquinol dose response: by day 14 of a 4-week trial, trough plasma ubiquinol had nearly plateaued at 2.61 µg/mL on 90 mg, 3.66 µg/mL on 150 mg and 6.53 µg/mL on 300 mg a day, rising less than in proportion to dose¹⁴.
• Upper safe level: a risk assessment found strong evidence of safety up to 1,200 mg a day, the observed safe level¹⁵.
• Side effects don't rise with dose: nausea and gut upset were no more common at 1,200 mg than at 60 mg a day¹⁵.

In the healthy reference range, plasma CoQ10 sits between 0.40 and 1.91 µmol/L, and the half-life is about 33 hours, so steady levels build over several days⁷. Stopping is not a problem: supplemental CoQ10 does not suppress the body's own production and does not build up in plasma or tissues once you stop¹⁶.

The cautions are the same for both forms, because they are the same compound. No serious side effects have been reported; mild insomnia or digestive upset can occur¹¹.

• People on warfarin: CoQ10 may make warfarin work less well, which could raise the risk of a clot^{17, 11}.
• People using insulin: NCCIH lists a possible interaction with insulin, so blood sugar may need closer checks¹¹.
• People having cancer treatment: CoQ10 may not be compatible with some types of cancer therapy¹¹.
• Pregnancy and breastfeeding: safety has not been established, so Mayo Clinic advises using it only with a clinician's approval¹⁷.

Does CoQ10 affect liver or kidney tests?

The trial data don't suggest so. Ubiquinol at 90 to 300 mg a day for 4 weeks caused no clinically relevant changes in standard lab tests in healthy volunteers¹⁴. In 20 people on hemodialysis, doses up to 1,800 mg a day were safe in everyone and well tolerated by most of the 15 who finished¹⁸.

What if you take a statin?

Statins lower blood CoQ10: a meta-analysis of 8 placebo-controlled trial arms found an average drop of 0.44 µmol/L¹⁹. Whether replacing it eases statin muscle pain is disputed. One meta-analysis of 12 trials in 575 patients found less pain, weakness and cramps²⁰; another of 7 trials in 321 patients found no benefit for muscle pain and no effect on staying on the statin²¹. NCCIH concludes the overall evidence doesn't support CoQ10 for statin muscle pain¹¹.

Choose on formulation, price and the evidence for your goal, not on the oxidized or reduced label. A simple rule, based on the trials above:

• Heart failure, alongside your treatment: ubiquinone matches the trials that reduced cardiovascular deaths⁴.
• Fertility: either form; no trial has compared them for fertility^{12, 13}.
• A poor response on ubiquinone: ubiquinol is a reasonable switch, since some people responded better to it in a small crossover trial².
• Any form: pick a solubilized or dispersed formulation and take it with a meal^{6, 7}.

Mayo Clinic notes CoQ10 levels fall with age and can be lower in people taking statins¹⁷. Even so, blood levels after supplementation are not a proven measure of benefit, so a higher number on one product is not a reason to pay more^{2, 3}. For background on why CoQ10 matters to energy production, see CoQ10 and the electron transport chain and what mitochondria do.

Related health goals

• Antioxidant Protection
• CoQ10 Synthesis Support

We searched PubMed, the Cochrane Library and NCCIH and Mayo Clinic fact sheets on 24 October 2026 for head-to-head trials of ubiquinol and ubiquinone, absorption reviews, meta-analyses of CoQ10 outcomes, and safety assessments. We read 22 study records (21 with abstracts) and cited 19 of them, plus 2 fact sheets, prioritising randomized and crossover trials in adults and meta-analyses.

The evidence can't tell us whether either form leads to better health outcomes, because no outcome trial has compared them directly; the head-to-head trials measured blood levels only.

1. Langsjoen PH, et al. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clin Pharmacol Drug Dev. 2014;3(1):13-7. doi:10.1002/cpdd.73
2. Zhang Y, et al. Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men. Food Funct. 2018;9(11):5653-5659. doi:10.1039/c8fo00971f
3. D'Adamo CR, et al. A Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations. J Nutr Metab. 2026;2026:5589963. doi:10.1155/jnme/5589963
4. Fladerer JP, et al. Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality. Curr Cardiol Rep. 2023;25(12):1759-1767. doi:10.1007/s11886-023-01992-6
5. Pravst I, et al. Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals. Nutrients. 2020;12(3). doi:10.3390/nu12030784
6. Mantle D, et al. Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism. Antioxidants (Basel). 2020;9(5). doi:10.3390/antiox9050386
7. Bhagavan HN, et al. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006;40(5):445-53. doi:10.1080/10715760600617843
8. Judy WV. The Instability of the Lipid-Soluble Antioxidant Ubiquinol: Part 1-Lab Studies. Integr Med (Encinitas). 2021;20(4):24-28. https://pubmed.ncbi.nlm.nih.gov/34602873/
9. Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-9. doi:10.1016/j.jchf.2014.06.008 Our study summary.
10. Al Saadi T, et al. Coenzyme Q10 for heart failure. Cochrane Database Syst Rev. 2021;(2)(2):CD008684. doi:10.1002/14651858.CD008684.pub3 Our study summary.
11. National Center for Complementary and Integrative Health. Coenzyme Q10. https://www.nccih.nih.gov/health/coenzyme-q10
12. Lin G, et al. Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis. Ann Med. 2024;56(1):2389469. doi:10.1080/07853890.2024.2389469 Our study summary.
13. Bakri S, et al. Efficacy and Safety of Coenzyme Q10 in Idiopathic Male Infertility: A Systematic Review and Meta-Analysis of Randomized Trials. World J Mens Health. 2026;44(4):829-843. doi:10.5534/wjmh.250159
14. Hosoe K, et al. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007;47(1):19-28. doi:10.1016/j.yrtph.2006.07.001
15. Hathcock JN, et al. Risk assessment for coenzyme Q10 (Ubiquinone). Regul Toxicol Pharmacol. 2006;45(3):282-8. doi:10.1016/j.yrtph.2006.05.006
16. Hidaka T, et al. Safety assessment of coenzyme Q10 (CoQ10). Biofactors. 2008;32(1-4):199-208. doi:10.1002/biof.5520320124
17. Mayo Clinic Staff. Coenzyme Q10. Mayo Clinic; 2025. https://www.mayoclinic.org/drugs-supplements-coenzyme-q10/art-20362602
18. Yeung CK, et al. Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress. BMC Nephrol. 2015;16:183. doi:10.1186/s12882-015-0178-2
19. Banach M, et al. Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res. 2015;99:329-36. doi:10.1016/j.phrs.2015.07.008 Our study summary.
20. Qu H, et al. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2018;7(19):e009835. doi:10.1161/JAHA.118.009835 Our study summary.
21. Kennedy C, et al. Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis. Atherosclerosis. 2020;299:1-8. doi:10.1016/j.atherosclerosis.2020.03.006